Consolidated Planning Corp raised its holdings in Target Co. (NYSE:TGT – Get Rating) by 1.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,977 shares of the retailer’s stock after buying an additional 156 shares during the quarter. Consolidated Planning Corp’s holdings in Target were worth $2,371,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TGT. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in Target by 3,577.5% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,471 shares of the retailer’s stock valued at $312,000 after buying an additional 1,431 shares during the period. Zions Bancorporation N.A. grew its holdings in Target by 3.3% in the 1st quarter. Zions Bancorporation N.A. now owns 3,045 shares of the retailer’s stock valued at $646,000 after buying an additional 96 shares during the period. Covestor Ltd grew its holdings in Target by 131.7% in the 1st quarter. Covestor Ltd now owns 702 shares of the retailer’s stock valued at $149,000 after buying an additional 399 shares during the period. Merit Financial Group LLC purchased a new stake in shares of Target during the 1st quarter worth about $208,000. Finally, Ergoteles LLC grew its holdings in shares of Target by 191.5% during the 1st quarter. Ergoteles LLC now owns 11,794 shares of the retailer’s stock worth $2,503,000 after purchasing an additional 7,748 shares during the period. Hedge funds and other institutional investors own 78.86% of the company’s stock.
Target Price Performance
Shares of NYSE TGT opened at $163.00 on Wednesday. The company has a current ratio of 0.86, a quick ratio of 0.14 and a debt-to-equity ratio of 1.29. The company has a market capitalization of $75.02 billion, a price-to-earnings ratio of 22.40, a price-to-earnings-growth ratio of 3.02 and a beta of 1.03. Target Co. has a twelve month low of $137.16 and a twelve month high of $254.87. The business has a 50 day simple moving average of $155.59 and a 200-day simple moving average of $158.95.
Target Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 10th. Investors of record on Wednesday, February 15th will be paid a dividend of $1.08 per share. The ex-dividend date of this dividend is Tuesday, February 14th. This represents a $4.32 annualized dividend and a yield of 2.65%. Target’s dividend payout ratio (DPR) is 59.18%.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. KeyCorp decreased their target price on Target from $200.00 to $180.00 and set an “overweight” rating for the company in a report on Thursday, November 17th. Jefferies Financial Group upgraded Target from a “hold” rating to a “buy” rating and boosted their target price for the stock from $170.00 to $185.00 in a report on Tuesday, October 18th. Sanford C. Bernstein assumed coverage on Target in a report on Tuesday, December 6th. They set an “outperform” rating and a $190.00 target price for the company. Raymond James decreased their target price on Target from $200.00 to $185.00 and set a “strong-buy” rating for the company in a report on Thursday, November 17th. Finally, UBS Group decreased their target price on Target from $205.00 to $194.00 and set a “buy” rating for the company in a report on Thursday, November 17th. Twelve research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Target currently has an average rating of “Moderate Buy” and an average price target of $181.07.
Target Corp. engages in the operation and ownership of general merchandise stores. It offers food assortments including perishables, dry grocery, dairy, and frozen items. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.
- Get a free copy of the StockNews.com research report on Target (TGT)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- Is It Time To Get Aggressive With Defense Stocks?
Receive News & Ratings for Target Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target and related companies with MarketBeat.com's FREE daily email newsletter.